10-K: Verano Holdings Corp. Navigates Cannabis Market Dynamics in 2024 Annual Report

Verano Holdings Corp.'s 2024 annual report reveals strategic navigation through evolving cannabis markets, highlighting both challenges and growth opportunities.

Summary

• Verano Holdings Corp.'s 2024 annual report provides an overview of the company's operations, financial performance, and strategic direction within the U.S. cannabis industry.
• As of February 25, 2025, Verano operates in 13 states with 153 retail dispensaries and 15 cultivation and processing facilities.
• The company's revenue for 2024 was $878.6 million, a decrease from $938.5 million in 2023, attributed to increased competition in key markets like New Jersey and Illinois.
• Medical-use sales comprised 51% of consolidated revenues, while adult-use sales accounted for 49%.
• The company incurred a net loss of $341.9 million in 2024, compared to a net loss of $117.3 million in 2023, primarily due to significant impairment charges.
• Verano made strategic acquisitions in Arizona and Virginia to expand its retail footprint and cultivation capacity.
• The company prepaid $50 million of its senior secured term loan in April 2024, demonstrating its commitment to debt management.
• Verano is actively monitoring and adapting to the evolving regulatory landscape, including potential federal rescheduling of cannabis.
• The company emphasizes compliance with state and local laws, despite the ongoing federal illegality of cannabis.
• Verano is committed to social equity initiatives, supporting communities affected by cannabis prohibition.

Sentiment

Score: 5

Explanation: The document presents a mixed sentiment. While Verano maintains a strong market presence and is strategically expanding, the significant net loss and challenges related to the regulatory environment temper the overall outlook.

Positives

• Verano maintains a significant presence in key cannabis markets across the U.S.
• The company is proactively managing its debt through prepayments.
• Verano is expanding its operations through strategic acquisitions.
• The company is committed to social equity and community support.
• Verano is actively monitoring and adapting to the evolving regulatory landscape.

Negatives

• Verano experienced a decrease in revenue in 2024 compared to 2023.
• The company incurred a substantial net loss in 2024, primarily due to impairment charges.
• Verano faces ongoing challenges related to the federal illegality of cannabis.
• The company is subject to intense competition in key markets.
• Verano is exposed to risks related to regulatory changes and potential enforcement actions.

Risks

• The federal illegality of cannabis poses a significant risk to Verano's operations.
• Regulatory changes at the federal, state, and local levels could adversely affect the company.
• Economic uncertainty and market disruptions may negatively impact Verano's business.
• The company faces risks related to its outstanding indebtedness and ability to repay.
• Competition from other cannabis operators and the illicit market could impact Verano's market share.
• The company is subject to potential product liability claims and recalls.
• Verano relies on key management personnel, and their loss could negatively affect the business.
• The company's intellectual property may be difficult to protect.
• Verano is subject to cybersecurity risks and potential data breaches.
• The company may face challenges in accessing banking and financial services due to federal regulations.

Future Outlook

The company plans to continue growing its wholesale and retail operations by entering new markets and expanding in current markets, including when medical markets expand into adult use markets. Growth plans include applying for new licenses, acquiring existing licensed businesses in limited license markets and maximizing operations under existing licenses.

Management Comments

• Verano's goal is the ongoing development of communal wellness by providing responsible access to medical and adult use regulated cannabis products.
• The company's strategy is to vertically integrate as a single cohesive company in multiple states through consolidation of seed-to-sale cultivating, processing, wholesale distributing, and dispensing branded products at scale.
• The company emphasizes developing high-quality products at various price points to elevate its products market desirability and value.
• The company aims to adhere to standard operating procedures across all of its cultivation and processing facilities, growing with state-permitted products and implementing compliance programs to meet product testing, inventory controls and other state regulatory requirements.
• The company espouses a customer and patient driven business philosophy aiming to deliver value to its downstream patients and consumers.

Industry Context

Verano operates in a competitive U.S. cannabis market, facing competition from multi-state operators, out-of-state operators, and the illicit market. The company is adapting to evolving state regulations and potential federal changes, while navigating challenges related to banking access and taxation.

Comparison to Industry Standards

• Verano competes with other publicly traded multi-state operators such as Green Thumb Industries Inc., Cresco Labs, Inc., Curaleaf Holdings, Inc., and Trulieve Cannabis Corp.
• The company's performance is affected by factors such as state-by-state regulatory landscapes, competition, and access to capital, similar to other companies in the cannabis sector.
• Verano's focus on vertical integration and brand development aligns with strategies employed by other leading cannabis companies.
• The company's challenges related to Section 280E of the Internal Revenue Code are common among cannabis businesses in the U.S.

Corporate Governance

Legal Proceedings

• Verano is currently involved in litigation with Vireo Growth Inc., formerly known as Goodness Growth Holdings, Inc. (GGH) arising from the termination of the GGH Arrangement Agreement.
• GGH is seeking $860.9 million in damages, plus costs and interest.
• Verano has filed a counterclaim seeking a termination fee of $14.875 million or reimbursement of out-of-pocket fees and expenses of up to $3 million.

Related Party Transactions

• George Archos, the Chairman and Chief Executive Officer of the Company, participated in the 2022 Credit Agreement as a Lender funding $1 million of the $350 million principal amount.
• The Company leases real property for a retail dispensary in Aurora, Illinois from 740 Rte. 59, LLC, an entity in which George Archos holds a 50% ownership interest.
• The Company leases real property for a retail dispensary in Lombard, Illinois from 783 Butterfield LLC, an entity in which George Archos holds a 50% ownership interest.
• GP Management Group, LLC, an entity beneficially owned and controlled by George Archos, held an ownership interest of less than 1% ownership interest in Sweed as of December 31, 2024.

Stakeholder Impact

• Shareholders may be concerned about the decrease in revenue and the significant net loss.
• Employees may face uncertainty due to potential cost-cutting measures or restructuring.
• Customers may experience changes in product availability or pricing.
• Suppliers may be affected by changes in Verano's purchasing patterns.
• Creditors may be concerned about Verano's ability to repay its debt.

Next Steps

• The company will continue to monitor proposed changes to existing cannabis laws and regulations.
• The company will continue to monitor the enactment of new cannabis laws and regulations.
• The company will continue to monitor its compliance with applicable existing cannabis laws and regulations on an ongoing basis in accordance with its compliance program and standard operating procedures.

Key Dates